BIIB vs GILD
Biogen Inc. and Gilead Sciences, Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | BIIB | GILD |
|---|---|---|
| Revenue | $9.9B | $29.4B |
| Net income | $1.3B | $8.5B |
| Gross margin | 75.7% | 78.8% |
| Net margin | 13.1% | 28.9% |
| Return on equity | 7.4% | 40.5% |
| Diluted EPS | $8.79 | $6.78 |
| Dividend / share | · | $3.16 |
| Payout ratio | · | 47.0% |
| Free cash flow | $2.1B | $9.5B |
| Equity | · | $22.7B |
| Net debt / equity | 0.18× | 0.77× |
| Current ratio | 2.68× | 1.55× |
| Revenue CAGR 5y | −6.0% | 3.6% |
| Profit CAGR 5y | −20.2% | 133.3% |
GILD bills 3.0× the revenue of BIIB, and keeps more of each dollar of revenue as profit (28.9% against 13.1%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | BIIB | GILD |
|---|---|---|
| FY2025 | $9.9B | $29.4B |
| FY2024 | $9.7B | $28.8B |
| FY2023 | $9.8B | $27.1B |
| FY2022 | $10.2B | $27.3B |
| FY2021 | $11.0B | $27.3B |
| FY2020 | $13.4B | $24.7B |
| FY2019 | $14.4B | $22.4B |
| FY2018 | $13.5B | $22.1B |
| FY2017 | $12.3B | $26.1B |
| FY2016 | $11.4B | $30.4B |
Bottom line
| Fiscal year | BIIB | GILD |
|---|---|---|
| FY2025 | $1.3B | $8.5B |
| FY2024 | $1.6B | $480.0M |
| FY2023 | $1.2B | $5.7B |
| FY2022 | $3.0B | $4.6B |
| FY2021 | $1.6B | $6.2B |
| FY2020 | $4.0B | $123.0M |
| FY2019 | $5.9B | $5.4B |
| FY2018 | $4.4B | $5.5B |
| FY2017 | $2.5B | $4.6B |
| FY2016 | $3.7B | $13.5B |
19 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −$19,552,400,000 | GILD |
| FY2024 | −$19,078,100,000 | GILD |
| FY2023 | −$17,280,400,000 | GILD |
| FY2022 | −$17,107,600,000 | GILD |
| FY2021 | −$16,323,300,000 | GILD |
| FY2020 | −$11,244,400,000 | GILD |
| FY2019 | −$8,071,100,000 | GILD |
| FY2018 | −$8,674,100,000 | GILD |
| FY2017 | −$13,833,100,000 | GILD |
| FY2016 | −$18,941,200,000 | GILD |
| FY2015 | −$21,875,200,000 | GILD |
| FY2014 | −$15,186,700,000 | GILD |
| FY2013 | −$4,269,800,000 | GILD |
| FY2012 | −$4,185,539,000 | GILD |
| FY2011 | −$3,336,751,000 | GILD |
| FY2010 | −$3,232,997,000 | GILD |
| FY2009 | −$2,634,035,000 | GILD |
| FY2008 | −$1,238,243,000 | GILD |
| FY2007 | −$1,058,428,000 | GILD |
GILD has reported the higher revenue in every one of these 19 fiscal years. The gap has widened since the earliest year compared.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.
19 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −15.8 pp | GILD |
| FY2024 | +15.2 pp | BIIB |
| FY2023 | −8.9 pp | GILD |
| FY2022 | +12.4 pp | BIIB |
| FY2021 | −7.0 pp | GILD |
| FY2020 | +29.8 pp | BIIB |
| FY2019 | +17.1 pp | BIIB |
| FY2018 | +8.6 pp | BIIB |
| FY2017 | +4.0 pp | BIIB |
| FY2016 | −12.1 pp | GILD |
| FY2015 | −22.1 pp | GILD |
| FY2014 | −18.1 pp | GILD |
| FY2013 | −0.4 pp | GILD |
| FY2012 | −1.5 pp | GILD |
| FY2011 | −8.2 pp | GILD |
| FY2010 | −17.3 pp | GILD |
| FY2009 | −15.1 pp | GILD |
| FY2008 | −17.6 pp | GILD |
| FY2007 | −19.0 pp | GILD |
The higher net margin has changed hands between BIIB and GILD over this period.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
GILD's net margin has been more volatile than BIIB's over the 19 comparable fiscal years — 13.7 percentage points of standard deviation against 7.7.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between BIIB and GILD over these 19 fiscal years — BIIB led in 6 and GILD in 13.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
GILD's return on equity has been more volatile than BIIB's over the 19 comparable fiscal years — 25.9 percentage points of standard deviation against 10.4.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between BIIB and GILD over these 19 fiscal years — BIIB led in 5 and GILD in 14.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.